Vendor, New York, NY
Castlevax Inc.
UEI FLZ6THBQ53N3, CAGE 9M4Y5
1 award and -$103,934 obligated between February 22, 2024 and March 27, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | -$103,934 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | -$103,934 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50123C00065Definitive Contract, February 22, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | No Cost Modification to Extend the Base Period of Performance.NAICS 541714, PSC AN13 | -$103,934 |
- Places of performance
- New York
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 5 across 1 awards